• M Rosario Torres Aguilar, Pilar Carrasco Salas, Cristina Santos Rosa, Guadalupe Bueno Rodríguez, Eduardo Martínez-Bonet, Práxedes Carreto Alba, Antonio León-Justel, and M Reyes Granell Escobar.
• Prenatal Diagnosis Unit, Obstetrics and Gynecology Department, Juan Ramón Jiménez Hospital, Huelva, Spain.
• Taiwan J Obstet Gynecol. 2021 Jul 1; 60 (4): 745-751.

ObjectiveTo analyze the results of contingent screening for common aneuploidies at our center from June 2017 to June 2019.Materials And MethodsTraditional screening tests were performed using a combination of biochemical markers and ultrasound measurements in the first and second trimesters to assess the risk of trisomies 21 (T21), 18 (T18) and 13 (T13). Cell-free DNA (cf-DNA) testing was offered (Harmony test) to pregnant women at high risk (>1/280 for T21 and > 1/150 for T13 and T18) and a normal early morphology scan. In positive cases, prenatal sampling was strongly recommended to confirm the results by gold standard methods (QF-PCR and karyotyping). Newborns' phenotypes were corroborated after birth in all cases.ResultsIn this prospective study, 8153 pregnant women were enrolled, resulting in 390 at high risk according to traditional screening tests. cfDNA testing was offered to 383 women. Traditional screening tests showed a false negative rate of 9.68% for T21. Traditional test sensitivity for T21 was 90.3%, for a false positive rate of 4.17% and a positive predictive value of 7.6%. The positive and negative predictive value for cfDNA testing was 100%. The approach used avoided invasive procedures in 91.3% of women at high risk. The prevalence of chromosomal abnormalities in the population analyzed was 1 in 164, and 1 in 210 for T21.ConclusionsOur results show that offering cf-DNA testing to women at high risk in traditional tests (including those with risks >1 in 50) significantly reduces false positives and, therefore, the number of invasive tests. Extending the use of cf-DNA testing to intermediate risk categories may be cost effective.Copyright © 2021. Published by Elsevier B.V.

28 keywords...

hide…